A Resolution directing the Joint State Government Commission to conduct a study on pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.
This Pennsylvania House Resolution directs the Joint State Government Commission to study pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. The study will examine current insurance coverage for treatments, the number of available specialists, common misdiagnoses, and policy actions taken by other states. The Commission is required to consult with medical organizations, insurers, and advocacy groups before submitting a report with recommendations to the House within 18 months.
Bill status
passed
3 of 5 stages cleared
Introduction
May 2026
Committee Review
May 2026
House Passage
Jun 2026
Senate Passage
Governor
Introduced May 14, 2026
Last action Jun 30, 2026
Maddy AI version diff · 1 comparison
What changed between versions
Printer's No. PN3413
→
Printer's No. PN3635
·
4 edits
MODERATE
The bill was substantially rewritten to expand its scope from a general study on PANS/PANDAS to a comprehensive mandate requiring specific analysis of insurance coverage, provider capacity, and legislative actions in other states. The revision adds detailed requirements for the Joint State Government Commission to consult with specific medical and advocacy groups and sets a strict 18-month deadline for submitting the final report.
Scope change
The bill's scope expanded from a general directive to conduct a study to a detailed mandate specifying exactly what topics must be examined, including insurance decision-making processes and provider expertise levels.
REQUIREMENT
Added a specific requirement for the commission to consult with a defined list of state medical organizations, national experts, advocacy groups, and health insurers.
TIMELINE
Established a mandatory deadline of 18 months after adoption for the commission to issue its final report.
SCOPE
Replaced the original brief list of study topics with a detailed, numbered list requiring analysis of insurance coverage justifications, estimated provider counts, and comparative state legislation.
DEFINITION
Included a new 'Whereas' clause providing a detailed definition of PANS and PANDAS, noting they are immune-mediated disorders that may be triggered by infections.
Floor votes · House Jun 30, 2026
How they voted
200–1
Passed
Total votes 201
Jun 30, 2026
D
Democratic102
100% Yea
R
Republican99
98% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
3
Key actions
2
Committee
1
Amendments
1
Jun 30, 2026
Lower · Passed
Adopted
lower
Jun 17, 2026
Lower · Passed
Reported as amended
lower
May 14, 2026
Committee
Referred to Health
lower
1 primary · 9 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 528
Scope: PA
Hi! I can help you understand HR 528. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline